RESULTS : In a pooled analysis of 1460 ICH and 3817 IS/TIA , MB were more frequent in ICH vs IS/TIA in all treatment groups , but the excess increased from 2.8 ( odds ratio ; range , 2.3-3.5 ) in nonantithrombotic users to 5.7 ( range , 3.4-9.7 ) in antiplatelet users and 8.0 ( range , 3.5-17.8 ) in warfarin users ( P difference=0.01 ) .
O O O O O O O O B-DiseaseOrPhenotypicFeature O O I-DiseaseOrPhenotypicFeature O B-DiseaseOrPhenotypicFeature O O O O B-DiseaseOrPhenotypicFeature O I-DiseaseOrPhenotypicFeature O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-ChemicalEntity O O O O O O